BackClearside Biomedical Overview

Clearside Biomedical Receivables

Clearside Biomedical's receivables is $270K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$266000.00
66.24% YoYΔ $-522000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Clearside Biomedical Receivables History

Loading

Clearside Biomedical vs. peers: Receivables Comparison

Loading

Clearside Biomedical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clearside Biomedical (CLSD) FAQ

The latest receivables for CLSD is $270K as of September 2025. That compares with $790K in the prior-year period — down 66.2% year over year. Investors often review this figure alongside Clearside Biomedical's historical trend and sector peers before judging valuation or financial health.

Over the past year, CLSD's receivables moved from $790K to $270K — a 66.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clearside Biomedical's operating scale or balance-sheet position.

A receivables figure of $270K for CLSD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CLSD's receivables ($270K), review year-over-year change from $790K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Clearside Biomedical's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.